Nutex Health Inc
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| March 28, 2024 | /s/ Thomas T. Vo |
|---|---|
| Thomas T. Vo, M.D. | |
| | Chief Executive Officer and Chairman of the Board(principal executive officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| | |
|---|---|
| March 28, 2024 | /s/ Thomas T. Vo |
| Thomas T. Vo, M.D. | |
| | Chief Executive Officer and Chairman of the Board(principal executive officer) |
| March 28, 2024 | /s/ Jon C. Bates |
| Jon C. Bates | |
| | Chief Financial Officer(principal financial officer and principal accounting officer) |
| March 28, 2024 | /s/ Warren Hosseinion |
| Warren Hosseinion | |
| | President and Director |
| March 28, 2024 | /s/ Danniel Stites |
| Danniel Stites, M.D. | |
| | Director |
| March 28, 2024 | /s/ Cheryl Grenas |
| Cheryl Grenas, R.N., M.S.N. | |
| | Director |
| March 28, 2024 | /s/ Michael L. Reed |
| Michael L. Reed | |
| | Director |
| March 28, 2024 | /s/ Mitchell Creem |
| Michell Creem | |
| | Director |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.